FDA moves toward easing restrictions on certain peptides BioPharma Dive What is BPC 157? Everything to know about this peptide The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The peptide problem: Hype is outrunning the evidence High level overview of pathways modulated by BPC 157. It is important Download Scientific Diagram